Potent antitumor activity after systemic delivery of a doubly fusogenic oncolytic herpes simplex virus against metastatic prostate cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/B5F9EB14.svg?ark=w1%2F20260515%2FB5F9EB14)](https://nobleid.org/work/w1/20260515/B5F9EB14)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors